" /> Allogeneic Anti-HA-2 TCR-engineered T-cells TSC-101 - CISMeF





Preferred Label : Allogeneic Anti-HA-2 TCR-engineered T-cells TSC-101;

NCIt synonyms : T-cell Receptor Engineered Donor T-Cells TSC-101; HA-2-targeting TCR-T-cells TSC-101; Allogeneic T-cell Receptor-engineered T-cells TSC-101;

NCIt definition : A preparation of donor-derived T-lymphocytes that have been genetically engineered to express a T-cell receptor (TCR) specific for HLA-A*02:01-restricted minor histocompatibility antigen HA-2 (HA2), with potential immunomodulating and antineoplastic activities. Following allogeneic haploidentical hematopoietic cell transplantation (HCT) in HLA-A*02:01 positive patients, allogeneic anti-HA-2 TCR-engineered T-cells TSC-101 specifically recognize and bind to HA-2 expressed on tumor cells. This may lead to cytotoxic T-lymphocyte (CTL)-mediated elimination of tumor cells expressing HA-2. HA-2 is a lineage-specific antigen found on leukemia cells.;

Molecule name : TSC-101; TSC 101;

NCI Metathesaurus CUI : CL1799390;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.